Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 5

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects

Authors Kapoor S

Received 17 March 2012

Accepted for publication 19 March 2012

Published 11 May 2012 Volume 2012:5 Pages 121—123


Shailendra Kapoor

Mechanicsville, Richmond, VA, USA

I read with great interest the article by Andukuri et al in a recent issue of your journal.1 The article makes compelling reading. Interestingly, research over the past few years has shown that in addition to its significant diabetic-modulating effects, alogliptin also exerts significant direct antiatherosclerotic effects.

View original paper by Andukuri and colleagues

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.